L A Adler

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    Clin Ther 34:363-73. 2012
  2. ncbi A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
    Timothy E Wilens
    Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Behav Brain Funct 4:24. 2008
  3. ncbi Attention-deficit/hyperactivity disorder in adult patients with posttraumatic stress disorder (PTSD): is ADHD a vulnerability factor?
    L A Adler
    New York University School of Medicine, NY 10016, USA
    J Atten Disord 8:11-6. 2004
  4. ncbi Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms
    Lenard A Adler
    Department of Psychiatry and Neurology, Adult ADHD Program, NYU School of Medicine, New York, NY 10016, USA
    Ann Clin Psychiatry 18:145-8. 2006
  5. ncbi Combination pharmacotherapy for adult ADHD
    Lenard A Adler
    Faculty Practice Offices, NYU School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Curr Psychiatry Rep 8:409-15. 2006
  6. ncbi Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Clin Psychopharmacol 26:648-52. 2006
  7. ncbi Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial
    Lenard A Adler
    NYU School of Medicine, New York VA Harbor Healthcare System, New York, NY 10016, USA
    J Clin Psychopharmacol 29:44-50. 2009
  8. ncbi Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, 530 First Ave 7D, New York, NY 10016, USA
    J Clin Psychiatry 69:1364-73. 2008
  9. ncbi Functional outcomes in the treatment of adults with ADHD
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, NY 10010, USA
    J Atten Disord 11:720-7. 2008
  10. ncbi The reliability and validity of self- and investigator ratings of ADHD in adults
    Lenard A Adler
    New York University School of Medicine, New York, NY 10016, USA
    J Atten Disord 11:711-9. 2008

Detail Information

Publications42

  1. ncbi Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA
    Clin Ther 34:363-73. 2012
    ..As a first step, we present the results of a post hoc, pooled analysis that compared the efficacy and safety profile of atomoxetine in these 2 patient populations...
  2. ncbi A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
    Timothy E Wilens
    Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Behav Brain Funct 4:24. 2008
    ..abstract:..
  3. ncbi Attention-deficit/hyperactivity disorder in adult patients with posttraumatic stress disorder (PTSD): is ADHD a vulnerability factor?
    L A Adler
    New York University School of Medicine, NY 10016, USA
    J Atten Disord 8:11-6. 2004
    ..This study examined the association between PTSD and ADHD using retrospective and current clinical evaluations...
  4. ncbi Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms
    Lenard A Adler
    Department of Psychiatry and Neurology, Adult ADHD Program, NYU School of Medicine, New York, NY 10016, USA
    Ann Clin Psychiatry 18:145-8. 2006
    ..The goal of this study was to validate the pilot Adult ADHD Self-Report Scale (pilot ASRS) versus standard clinician ratings on the ADHD Rating Scale (ADHD RS)...
  5. ncbi Combination pharmacotherapy for adult ADHD
    Lenard A Adler
    Faculty Practice Offices, NYU School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Curr Psychiatry Rep 8:409-15. 2006
    ..Adjunct treatment of mirtazapine to stimulant medications reduced associated insomnia. These data support previous research that validates the use of combination pharmacotherapy for adults with ADHD...
  6. ncbi Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA
    J Clin Psychopharmacol 26:648-52. 2006
    ..Despite the existence of research demonstrating the effects of ADHD on certain aspects of life, the clinical trials of treatments for this disorder have focused primarily on efficacy and safety...
  7. ncbi Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial
    Lenard A Adler
    NYU School of Medicine, New York VA Harbor Healthcare System, New York, NY 10016, USA
    J Clin Psychopharmacol 29:44-50. 2009
    ..Atomoxetine demonstrated significant efficacy that continued into the evening. Adverse events were similar to previous trials...
  8. ncbi Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, 530 First Ave 7D, New York, NY 10016, USA
    J Clin Psychiatry 69:1364-73. 2008
    ..To evaluate the efficacy and safety of 30, 50, and 70 mg/day lisdexamfetamine dimesylate compared with placebo in adults with attention-deficit/hyperactivity disorder (ADHD)...
  9. ncbi Functional outcomes in the treatment of adults with ADHD
    Lenard A Adler
    Department of Psychiatry, New York University School of Medicine, New York, NY 10010, USA
    J Atten Disord 11:720-7. 2008
    ..ADHD is associated with significant functional impairment in adults. The present study examined functional outcomes following 6-month double-blind treatment with either atomoxetine or placebo...
  10. ncbi The reliability and validity of self- and investigator ratings of ADHD in adults
    Lenard A Adler
    New York University School of Medicine, New York, NY 10016, USA
    J Atten Disord 11:711-9. 2008
    ....
  11. ncbi Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study
    Lenard A Adler
    NYU School of Medicine, New York VA Harbor Healthcare System, New York, NY 10016, USA
    J Clin Psychopharmacol 29:239-47. 2009
    ..To assess the efficacy and safety of OROS methylphenidate (Concerta; McNeil Pediatrics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, Titusville, NJ) in the management of attention-deficit/hyperactivity disorder (ADHD) in adults...
  12. ncbi Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence
    Lenard Adler
    Department of Psychiatry and Child and Adolescent Psychiatry, New York University Langone School of Medicine, 530 First Avenue, 7D, New York NY 10016, USA
    Am J Addict 18:393-401. 2009
    ..Vital signs and measures of hepatic function were not significantly different among the 3 drinking status groups taking atomoxetine...
  13. ncbi Management of ADHD in adults
    Lenard A Adler
    Department of Clinical Psychiatry and Neurology, New York University School of Medicine, 530 First Avenue, Suite 5A, New York, NY 10016, USA
    J Clin Psychiatry 63:29-35. 2002
    ..This article reviews the history, neurobiology, and pharmacologic management of adult ADHD...
  14. ncbi Clinical presentations of adult patients with ADHD
    Lenard A Adler
    Combined Psychiatry and Neurology Adult ADHD Program, New York University School of Medicine, New York 10016, USA
    J Clin Psychiatry 65:8-11. 2004
    ..These reports also stress the high probability of comorbid disorders and family aggregation of ADHD, as well as the likelihood that the adult with ADHD has developed coping mechanisms to compensate for his or her impairment...
  15. ncbi Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study
    Lenard A Adler
    New York University, School of Medicine, New York, NY 10016, USA
    J Atten Disord 12:248-53. 2008
    ..Previously, data from 97 weeks of open-label atomoxetine treatment of adults with attention-deficit/hyperactivity disorder (ADHD) were reported. This final report of that study presents results from over 4 years of treatment...
  16. ncbi Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
    Lenard Adler
    Department of Psychiatry, New York University School of Medicine, FPO Offices, 530 First Avenue, Suite 5A, New York, NY 10016, USA
    Psychiatr Clin North Am 27:187-201. 2004
    ..Accordingly, adult ADHD remains a clinical diagnosis, and the clinician-administered interview remains the cornerstone of diagnostic evaluation...
  17. ncbi Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD
    Lenard A Adler
    New York University School of Medicine, New York, NY 10016, USA
    J Atten Disord 12:449-59. 2009
    ..This study evaluates dexmethylphenidate extended release (d-MPH-ER) in adults with ADHD...
  18. ncbi Training raters to assess adult ADHD: reliability of ratings
    Lenard A Adler
    New York University School of Medicine, New York, NY 10016, USA
    J Atten Disord 8:121-6. 2005
    ..For the ADHDRS-IV-Inv, rater agreement was moderate, and reliability, as measured by Cronbach's alpha, was substantial. The data indicate that clinicians can be trained to reliably evaluate ADHD in adults using the ADHDRS-IV-Inv...
  19. ncbi Emotional dysregulation in adult ADHD and response to atomoxetine
    Frederick W Reimherr
    Mood Disorders Clinic, Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Biol Psychiatry 58:125-31. 2005
    ....
  20. ncbi Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD
    Lenard Adler
    School of Medicine, New York University, New York, NY, USA
    Ann Clin Psychiatry 18:107-13. 2006
    ..Changes in dosing strategy are unlikely to be accompanied by safety risks, implying that there is room for prescribers to use discretion and to base dosing strategies on individual factors...
  21. ncbi Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder
    Richard Weisler
    Department of Psychiatry, University of North Carolina, Chapel Hill, USA
    CNS Spectr 14:573-85. 2009
    ..To evaluate the long-term safety and effectiveness of lisdexamfetamine dimesylate (LDX) in the treatment of adults with attention-deficit/hyperactivity disorder (ADHD)...
  22. ncbi Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine
    Frederick Reimherr
    Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Psychiatry Res 175:67-73. 2010
    ..Although this study is speculative, it represents a pharmacologically and genotypically well-defined patient population...
  23. ncbi Epidemiology, impairments, and differential diagnosis in adult ADHD: introduction
    Lenard A Adler
    CNS Spectr 13:4-5. 2008
  24. ncbi ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study
    Timothy E Wilens
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Biol Psychiatry 59:1065-70. 2006
    ..This pilot study was designed to evaluate ABT-089, a neuronal nicotinic receptor partial agonist, as treatment for adult attention-deficit/hyperactivity disorder (ADHD)...
  25. ncbi Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
    Timothy E Wilens
    Massachusetts General Hospital, 55 Fruit Street, YAW 6900, Boston, MA 02114, USA
    Drug Alcohol Depend 96:145-54. 2008
    ..The study aim was to determine if atomoxetine was superior to placebo in improving ADHD and alcohol use in recently abstinent adults with ADHD and comorbid alcohol use disorder...
  26. ncbi Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis
    Reid J Robison
    Mood Disorders Clinic, Department of Psychiatry, University of Utah, Salt Lake City, UT 84132, USA
    J Clin Psychiatry 69:213-21. 2008
    ....
  27. ncbi Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales
    Kevin R Murphy
    Adult ADHD Clinic of Central Massachusetts, Northboro 01532, USA
    J Clin Psychiatry 65:12-7. 2004
    ..1 Symptom Checklist. More research is needed to establish the usefulness of self-administered rating scales compared with investigator-administered scales in the assessment and diagnosis of adult ADHD...
  28. ncbi Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis
    Lenard A Adler
    New York University, New York, USA
    J Clin Psychiatry 66:294-9. 2005
    ..CONCLUSION: The results of this interim analysis of an ongoing, open-label study of adults with ADHD support the long-term efficacy, safety, and tolerability of atomoxetine for the treatment of adult ADHD...
  29. ncbi Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Biol Psychiatry 57:1442-51. 2005
    ..Despite growing interest in adult attention-deficit/hyperactivity disorder (ADHD), little is known about predictors of persistence of childhood cases into adulthood...
  30. ncbi Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity
    Thomas J Spencer
    Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, USA
    J Clin Psychiatry 67:415-20. 2006
    ....
  31. ncbi Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder
    Thomas J Spencer
    Pediatric Psychopharmacology Research Clinic, Massachusetts General Hospital, Boston, Massachusetts 02114, and New York University School of Medicine, New York, NY, USA
    Biol Psychiatry 61:1380-7. 2007
    ..This multicenter, randomized, fixed-dose, double-blind, placebo-controlled study evaluated efficacy of extended-release dexmethylphenidate (d-MPH-ER) in adults with attention-deficit/hyperactivity disorder (ADHD)...
  32. ncbi Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study
    David Michelson
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind, USA
    J Clin Psychiatry 68:582-7. 2007
    ..Addition of a noradrenergic intervention in patients poorly or partially responsive to SSRIs may improve outcomes, but few well-controlled studies testing this hypothesis have been reported...
  33. ncbi Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members
    Ronald C Kessler
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Int J Methods Psychiatr Res 16:52-65. 2007
    ..90. The brevity and ability to discriminate DSM-IV cases from non-cases make the six-question ASRS Screener attractive for use both in community epidemiological surveys and in clinical outreach and case-finding initiatives...
  34. ncbi Non-stimulant trials of adult ADHD
    Lenard A Adler
    Adult ADHD Program, New York University School of Medicine, New York City, New York, USA
    CNS Spectr 12:11-3. 2007
  35. ncbi Familial transmission of ADHD and psychoactive substance use disorders
    Lenard A Adler
    Am J Psychiatry 165:11-2. 2008
  36. ncbi The impact, identification, and management of attention-deficit/hyperactivity disorder in adults. Introduction
    Lenard A Adler
    New York University Medical Center, New York, NY, USA
    CNS Spectr 12:1-2. 2007
  37. ncbi Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature
    Timothy E Wilens
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 47:21-31. 2008
    ..The purpose of this systematic review of the literature is to evaluate the extent and characteristics of stimulant misuse and diversion in attention-deficit/hyperactivity disorder (ADHD) and non-ADHD individuals...
  38. ncbi Functional and psychosocial impairment in adults with undiagnosed ADHD
    Stephen L Able
    US Outcomes Research, Lilly Research Laboratories, Indianapolis, IN 46285, USA
    Psychol Med 37:97-107. 2007
    ..Additionally, compare adults with undiagnosed and diagnosed ADHD to investigate possible reasons why the undiagnosed avoid clinical detection...
  39. ncbi From childhood into adulthood: the changing face of ADHD
    Lenard A Adler
    New York University Medical Center, New York, New York, USA
    CNS Spectr 12:6-9. 2007
  40. ncbi Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394
    James B Lohr
    Psychiatry Service, San Diego Department of Veterans Affairs Medical Center, California 92161, USA
    J Clin Psychopharmacol 22:196-200. 2002
    ..These findings indicate that clinician-modifiable factors related to medication usage can influence the outcome of TD and EPS in patients with persistent TD...
  41. ncbi Network homogeneity reveals decreased integrity of default-mode network in ADHD
    Lucina Q Uddin
    The Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, New York University Child Study Center, New York, NY 10016, USA
    J Neurosci Methods 169:249-54. 2008
    ..Network homogeneity provides a potential alternative method for assessing functional connectivity of specific large-scale networks in clinical populations...
  42. ncbi Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder
    F Xavier Castellanos
    Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, New York University Child Study Center, New York, NY 10016, USA
    Biol Psychiatry 63:332-7. 2008
    ....